An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU
Clinical trial NCT04109313 · COMPLETED
Trial details
- NCT number
- NCT04109313
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-24
- Primary completion
- 2022-09-09
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.